Essential trace metal excretion from rats with lead exposure and during chelation therapy.
Urinary excretion of lead, zinc, calcium, magnesium, iron, copper, sodium, and potassium was measured in rats daily for 1 week after a 6-week exposure to 10,000 micrograms/ml lead in drinking water. Beginning on the third day, half of the lead-exposed and control rats were injected intraperitoneally with calcium disodium ethylenediaminetetraacetate (EDTA) daily for 3 days. Whole blood, plasma, and kidney metal concentrations were determined from samples obtained at the end of the experiment. Exposure to lead increased urinary excretion, not only of lead, but also of calcium, magnesium, zinc, copper, and iron. Excretion of sodium and potassium was not altered. Chelation therapy further increased excretion of lead, zinc, copper, and iron, but not magnesium. The increase in calcium excretion during chelation treatment (beyond that resulting from lead exposure per se) was accounted for by the Ca content of CaNa2-EDTA. EDTA treatment increased renal concentration of zinc but lowered renal concentration of lead, copper, and iron. These multimetal alterations may have implications for essential metal supplementation, particularly zinc, in persons being given chelation agents for excess lead exposure and in infants and children with low-level lead exposure not necessarily requiring chelation therapy.
Victery
W
W
Miller
C R
CR
Goyer
R A
RA
D000818:Animals; D002136:Calcium, Dietary / Q000008:administration & dosage; D003300:Copper / Q000378:metabolism; D004435:Eating; D004492:Edetic Acid / Q000494:pharmacology*; D007501:Iron / Q000008:administration & dosage / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D007854:Lead / Q000378:metabolism / Q000633:toxicity*; D008297:Male; D051381:Rats; D014131:Trace Elements / Q000652:urine*; D015032:Zinc / Q000008:administration & dosage / Q000378:metabolism
D002136:Calcium, Dietary; D014131:Trace Elements; D007854:Lead; D003300:Copper; D004492:Edetic Acid; D007501:Iron; D015032:Zinc